Public trial registry of the CCC-Munich

Trial AGO-OVAR-20 (PAOLA-1)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AGO-OVAR-20 (PAOLA-1)
World
Full title
:

Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with
Advanced FIGO Stage IIIB – IV High Grade Serous or Endometrioid Ovarian, Fallopian
Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining
Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy
and in Maintenance

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Other tumors
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Holger Bronger Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Magnifier